House Committee Grills Drug Company Execs About Price Hikes

by Admin | February 4, 2016 4:45 pm

February 4, 2016—Former Turing Pharmaceuticals chief executive Martin Shkreli today invoked his Fifth Amendment right against self-incrimination in declining to answer a House committee’s questions about Turing’s 5,000 percent price increase for a potentially life-saving off-patent medicine lacking competition.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2016/02/house-committee-grills-drug-company-execs-about-price-hikes/

Copyright ©2026 340binformed.org unless otherwise noted.